🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with metastatic malignant melanoma will receive CP-4055 200 mg/m2/...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2007-03
Trial ID
NCT00498836
Treatments Being Tested
Patients with histologically or cytologically confirmed metastatic colorect...
Status
Completed
Location
Aberdeen Royal Infirmary, Foresterhill,
Start Date
2007-05
Trial ID
NCT00498407
Treatments Being Tested
This study is performed to measure the quantity of i.v. applied elacytarabi...
Status
Completed
Location
Quotient Clinical
Start Date
2013-02
Trial ID
NCT01783964
Treatments Being Tested
This is non randomised, open label, dose finding, efficacy and safety study...
Status
Completed
Location
U.Z. Gasthuisberg, Gynecologic Oncology, Herestraat 49
Start Date
2008-04
Trial ID
NCT00831636
The purpose of the study is to assess the efficacy and safety of elacytarab...
Status
Completed
Location
Scripps Cancer Center Clinical Research
Start Date
2010-06
Trial ID
NCT01147939
Treatments Being Tested
Patients with refractory or relapsed hematologic malignancies will receive ...
Status
Completed
Location
Mew York Medical College, Division of Oncology
Start Date
2006-05
Trial ID
NCT00405743
The purpose of the study is to investigate the pharmacokinetics (PK) and ca...
Status
Completed
Location
ICO - Hospital Duran i Reynals
Start Date
2010-10
Trial ID
NCT01258816
Treatments Being Tested
The main objective of this study is to assess the biological activity of el...
Status
Completed
Location
Duke University Medical Center
Start Date
2009-12
Trial ID
NCT01035502
Treatments Being Tested
Previously untreated patients with malignant melanoma receive a new chemoth...
Status
Completed
Location
University of Pittsburgh
Start Date
2005-09
Trial ID
NCT00232726
Treatments Being Tested